Search Results
Dec 03, 2025, 09:05 ET Linear Integrated Systems Introduces LSBF862: Superior Lower Noise N-Channel JFET Replacement for Discontinued NXP BF862
Voltage: BVGSS = 40V (Min)High Gain: Yfs = 45mS (typ)Low Capacitance: 10pF (typ)Available with Special Testing in SOT-23 (3L) and Bare-Die VersionsBare-Die Options AvailableBenefits:Lower Noise and Greater Precision Across
More news about: Linear Integrated Systems
Dec 03, 2025, 09:03 ET Stanley Black & Decker Appoints Agustin Lopez Diaz as Chief Global Supply Chain Officer
Company, effective December 15, 2025. Lopez Diaz joins Stanley Black & Decker from Schneider Electric and has more than 20 years of manufacturing, P&L, and supply chain leadership experience.
More news about: Stanley Black & Decker, Inc.
Dec 03, 2025, 09:00 ET Quadriga BioSciences Announces Encouraging Interim Phase II Results of LAT1-targeted QBS72S in Breast Cancer Patients with Leptomeningeal Disease
University School of Medicine that evaluated the safety and efficacy of QBS72S, a novel chemotherapeutic designed to cross the blood–brain barrier via the L-type amino acid transporter 1 (LAT1). The results showed that QBS72S produced both radiographic and symptomatic improvement in breast cancer patients
More news about: Quadriga BioSciences, Inc.
Dec 03, 2025, 09:00 ET Renerva Receives FDA IDE Approval to Commence First-in-Human Study of its Renerva PNM-CAP™ Device for Neuroma Pain
study will be conducted at The Ohio State University (OSU) Wexner Medical Center and led by Principal Investigator Amy M. Moore, MD, who holds the Robert L. Ruberg MD Alumni Endowed Chair of the Department of Plastic and Reconstructive Surgery.PNM-CAP™ is a novel nerve capping device designed
More news about: Renerva, Inc.
Dec 03, 2025, 08:30 ET First Capital Bank Announces Executive Chairman Harvey L. Glick's Appointment to South Carolina Governor's School Board
-- First Capital Bank (OTCQX: FCPB), headquartered at 304 Meeting Street in downtown Charleston, announced today that its Executive Chairman, Harvey L. Glick, has been appointed by Henry McMaster, Governor of South Carolina, to serve on the Board of Trustees of the South Carolina Governor's School for
More news about: First Capital Bank
Dec 03, 2025, 08:00 ET GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
NeurosurgeonSean Cavenaugh, MS, DABR, Medical PhysicistRichard Dalyai, MD, NeurosurgeonHeather Grillo, Nuclear Medicine TechnologistJennifer L. Griswold, MD, NeurosurgeonRegis G. Hoppenot, MD, NeurosurgeonBlane Jernigan, Medical PhysicistAndrew W. Ju, MD, Radiation
More news about: GT Medical Technologies
Dec 03, 2025, 07:45 ET Tampa General Hospital and Palantir Technologies Honored with Inno Award for Partnership of the Year by Tampa Bay Business Journal
not-for-profit, academic health system, is one of the largest hospitals in America and delivers world-class care as the region's only center for Level l trauma and comprehensive burn care. Tampa General Hospital is the highest-ranked hospital in the market in
More news about: Tampa General Hospital
Dec 03, 2025, 07:30 ET ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
LOTIS-7 includes Part 1 of the study with a 3+3 dose escalation in 3L/3L+ heavily pre-treated patients with ZYNLONTA doses starting at 90 µg/kg and then proceeding to 120 µg/kg and 150 µg/kg. Part 2 includes dose expansion in 2L/2L+ large B-cell lymphoma in the ZYNLONTA plus glofitamab arm at dose levels
More news about: ADC Therapeutics SA
Dec 03, 2025, 07:00 ET Enbridge Inc. Announces 3% Quarterly Dividend Increase for 2026
$0.27432Preference Shares, Series LUS$0.36612
More news about: Enbridge Inc.
Dec 03, 2025, 07:00 ET GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting
Global Impression Scales Specific to the Common Signs and Symptoms of GRIN-Related Neurodevelopmental DisorderPresenter: Russell L. Chin, MD, Medical Director, GRIN TherapeuticsSession date/time: Tuesday, December 9, 2025, 12:00-1:45 p.m. ESTAdditional information
More news about: GRIN Therapeutics Inc.
Dec 03, 2025, 05:00 ET Britannia Global Markets Receives Category 4 Membership of London Metal Exchange
https://www.britannia.com/L: https://www.linkedin.com/company/britannia-financial-group-limited/L:
More news about: Britannia Global Markets
Dec 03, 2025, 05:00 ET Cruise Critic Releases the 2025 'Best in Cruise Awards,' Naming the Best Cruises of the Year
future for Oceania Cruises."Cruisers' Choice Award: Viking CruisesAccording to Cruise Critic Member T L M: "Viking made our cruise experience effortless. From beginning to end the staff and crew anticipated our needs and exceeded our expectations. Our experience
More news about: Cruise Critic
Dec 03, 2025, 03:33 ET CS Analytical Adds USP 87 Biological Reactivity Testing to its Service Offering
place results into context—bridging to elastomer requirements (USP 381 / guidance 1381) or plastics programs (USP 661.1/661.2), and aligning with your E&L strategy (
More news about: CS Analytical
Dec 03, 2025, 03:15 ET Further & 3iQ Launch Digital Asset Market Neutral Multi-Strategy Hedge Fund
https://www.3iq.io/L:
More news about: 3iQ
Dec 03, 2025, 03:15 ET Further & 3iQ Launch Digital Asset Market Neutral Multi-Strategy Hedge Fund
https://www.3iq.io/L:
More news about: 3iQ
Dec 02, 2025, 16:40 ET New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
CA.Hampel H, Hardy J, Blennow K, et al. The amyloid-β pathway in Alzheimer's disease. Mol Psychiatry. 2021;26(10):5481-5503.Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021; 12:3451.
More news about: Eisai Inc.
Dec 02, 2025, 16:05 ET Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium
agent-of-choice and the Ziihera combinations to become the new standard of care for patients with HER2+ first-line metastatic GEA regardless of PD-L1 status. Alongside new analyses from the HERIZON-BTC-01 Phase 2b trial, these presentations highlight the continued impact of our broad zanidatamab clinical
More news about: Jazz Pharmaceuticals plc
Dec 02, 2025, 11:50 ET Power Unpacked: Dodge Unlocks Orders for SIXPACK-powered Charger R/T, Delivers Most Standard Horsepower of Any Muscle Car
Daytona Scat Pack – the world's quickest and most powerful muscle car. For 2026, the all-new 550-horsepower Dodge Charger Scat Pack, powered by the 3.0L Twin Turbo SIXPACK H.O. engine, expands the Charger lineup, powered by the most powerful Hurricane engine in production.Dodge also keeps its foot
More news about: Stellantis
Dec 02, 2025, 10:00 ET RWS Global Finalizes Board of Directors and Bolsters Advisory Board with New Appointments to Fuel Next Phase of Growth
Partners and a former executive at Apollo, Helios, and McKinsey & Company as fellow Board Directors.Rema Awad is a Partner at the law firm K&L Gates, and offers deep experience in mergers and acquisitions, private equity and corporate governance as a member of the RWS Global Advisory Board.
More news about: RWS Global
Dec 02, 2025, 09:07 ET Yesway Announces the Hiring of Chuck Sanders as Vice President of Merchandising
impact he will make across our organization."In his new role, Chuck will oversee all aspects of Yesway's merchandising function, including P&L ownership, category management, assortment optimization, vendor partnerships, strategic pricing, and planogram development. He will work cross-functionally
More news about: Yesway
Dec 02, 2025, 09:00 ET Coverage Expansion Continues for One- and Two-Level Lumbar Total Disc Replacement as One of the Leading Commercial Payers in Arizona Establishes Positive Coverage Criteria for Centinel Spine's prodisc® L
TDR.Reimbursement coverage for the prodisc L system continues to expand in the U.S.—with one-level at nearly 95% and two-level now over 40% of commercially covered lives.1prodisc L is the only lumbar total disc replacement system in the U.S.
More news about: Centinel Spine, LLC
Dec 02, 2025, 09:00 ET L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Procedure Within One Year of Launch
sectors –SEONGNAM, South Korea, Dec. 2, 2025 /PRNewswire/ -- L&C Bio (KOSDAQ: 290650, Co-CEOs Hwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based regenerative medicine, announced that its premium
More news about: L&C BIO Co., Ltd
Dec 02, 2025, 09:00 ET InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform
https://inskill.ai/l/frost-sullivan-industrial-ai-copilot-platform-award/ContactE: [email protected]
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform
https://inskill.ai/l/frost-sullivan-industrial-ai-copilot-platform-award/ContactE: [email protected]
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
paxalisib, a brain-penetrant dual PI3K/mTOR inhibitor currently in clinical trials for both brain cancer and advanced breast cancer, advancing the PD-L1 degrader program, and for general corporate purposes. The Company expects the net proceeds from the PIPE, combined with the existing cash and cash equivalents,
More news about: Kazia Therapeutics Limited